Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
19
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Forte Biosciences Inc market cap is $1.63B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Forte Biosciences Inc 52 week high is $77.20 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Forte Biosciences Inc 52 week low is $15.51 as of November 21, 2026.
Forte Biosciences Inc stock price today is $76.99.
Forte Biosciences Inc stock price yesterday was $76.97.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Forte Biosciences Inc's P/E ratio is -15.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Forte Biosciences Inc P/B ratio is 8.5799.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Forte Biosciences Inc 50-day moving average is $76.99.